We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+16.46%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$484M
AUM Growth
+$15.4M
Cap. Flow
-$55.9M
Cap. Flow %
-11.54%
Top 10 Hldgs %
55.19%
Holding
34
New
3
Increased
8
Reduced
21
Closed
2

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$25.6M
2
GILD icon
Gilead Sciences
GILD
+$18M
3
CERN
Cerner Corp
CERN
+$5.86M
4
HCA icon
HCA Healthcare
HCA
+$3.67M
5
MRK icon
Merck
MRK
+$2.28M

Top Sells

Rank Stock Value
1
INCY icon
Incyte
INCY
+$17M
2
UTHR icon
United Therapeutics
UTHR
+$15.4M
3
JNJ icon
Johnson & Johnson
JNJ
+$12.7M
4
ABT icon
Abbott
ABT
+$9.8M
5
BSX icon
Boston Scientific
BSX
+$9.35M

Sector Composition

Rank Sector Weight
1 Healthcare 98.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$124B
$37.9M 7.82%
644,533
-32,900
-5% -$1.97M
GILD icon
2
Gilead Sciences
GILD
$167B
$33.4M 6.89%
433,784
+234,365
+118% +$18M
MRK icon
3
Merck
MRK
$315B
$31.1M 6.41%
420,872
+30,288
+8% +$2.28M
INCY icon
4
Incyte
INCY
$23.4B
$28.7M 5.92%
275,987
-176,596
-39% -$17M
RVTY icon
5
Revvity
RVTY
$12.3B
$25.3M 5.22%
257,722
-20,800
-7% -$1.9M
BSX icon
6
Boston Scientific
BSX
$65.4B
$25M 5.16%
711,482
-259,500
-27% -$9.35M
MDT icon
7
Medtronic
MDT
$106B
$24.5M 5.05%
+266,800
New +$25.6M
ABT icon
8
Abbott
ABT
$175B
$23.9M 4.94%
261,939
-108,395
-29% -$9.8M
ALXN
9
DELISTED
Alexion Pharmaceuticals
ALXN
$19.4M 4%
172,780
+4,277
+3% +$454K
A icon
10
Agilent Technologies
A
$37.1B
$18.3M 3.77%
206,616
-50,100
-20% -$4.1M
ELV icon
11
Elevance Health
ELV
$80.9B
$18.1M 3.75%
69,002
-20,600
-23% -$5.5M
NUVA
12
DELISTED
NuVasive, Inc.
NUVA
$17.3M 3.58%
311,628
-3,200
-1% -$185K
BIIB icon
13
Biogen
BIIB
$30.4B
$17.2M 3.55%
64,220
-10,900
-15% -$3.28M
PRGO icon
14
Perrigo
PRGO
$1.48B
$16.1M 3.32%
290,593
-65,647
-18% -$3.46M
HUM icon
15
Humana
HUM
$48B
$14.1M 2.92%
36,457
-8,200
-18% -$3.07M
BRKR icon
16
Bruker
BRKR
$8.86B
$13.7M 2.83%
337,346
+10,500
+3% +$413K
BMRN icon
17
BioMarin Pharmaceuticals
BMRN
$11.5B
$13.4M 2.76%
108,482
-31,100
-22% -$3.09M
CAH icon
18
Cardinal Health
CAH
$53.5B
$12.3M 2.53%
234,792
+26,600
+13% +$1.37M
BIO icon
19
Bio-Rad Laboratories Class A
BIO
$8.15B
$11.9M 2.45%
26,270
-6,200
-19% -$2.74M
IONS icon
20
Ionis Pharmaceuticals
IONS
$8.99B
$11.2M 2.31%
189,981
-85,500
-31% -$4.76M
PDCO
21
DELISTED
Patterson Companies, Inc.
PDCO
$10.3M 2.12%
466,487
-63,730
-12% -$1.12M
CVS icon
22
CVS Health
CVS
$137B
$9.32M 1.92%
143,416
+22,556
+19% +$1.42M
RARE icon
23
Ultragenyx Pharmaceutical
RARE
$2.88B
$8.51M 1.76%
108,734
-36,338
-25% -$2.41M
DGX icon
24
Quest Diagnostics
DGX
$23.3B
$6.26M 1.29%
54,906
-58,136
-51% -$6.17M
ALNY icon
25
Alnylam Pharmaceuticals
ALNY
$35.7B
$6.17M 1.27%
41,684
-12,700
-23% -$1.71M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2020 Portfolio in Review

As of Q2 2020, Sector Gamma AS held 34 positions worth $484M, up 3.3% from $469M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Sector Gamma AS withdrew a net $55.9M in Q2 2020, closing 2 positions and reducing 21 holdings. Its most notable exit was United Therapeutics, an estimated $15.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Medtronic worth $24.5M.

  • Sector Gamma AS's largest Q2 2020 buy was Medtronic: 266,800 shares worth $24.5M.
  • Sector Gamma AS added most to Gilead Sciences in Q2 2020, an estimated $18M increase.
  • Sector Gamma AS's biggest Q2 2020 reduction was Incyte, cutting an estimated $17M.
  • Sector Gamma AS fully exited United Therapeutics in Q2 2020, selling an estimated $15.4M.
  • Sector Gamma AS's ten largest holdings make up 55% of its $484M portfolio in Q2 2020.
  • Sector Gamma AS opened 3 new positions and closed 2 in Q2 2020.
  • Sector Gamma AS's portfolio value rose 3.3% quarter-over-quarter to $484M.

Based on Sector Gamma AS's 13F filing for Q2 2020, filed 7 Aug 2020.